Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.
3.

Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder.

Stevenson RD, Wolraich ML.

Pediatr Clin North Am. 1989 Oct;36(5):1183-97. Review.

PMID:
2677938
4.

Stimulant therapy in attention deficit/hyperactivity disorder.

Baldwin RL.

J Ark Med Soc. 2003 Dec;100(6):203-6. Review.

PMID:
14661403
5.

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S; American Academy of Child and Adolescent Psychiatry.

J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2 Suppl):26S-49S. Review.

PMID:
11833633
6.

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.

Brown RT, Amler RW, Freeman WS, Perrin JM, Stein MT, Feldman HM, Pierce K, Wolraich ML; American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder.

Pediatrics. 2005 Jun;115(6):e749-57. Review.

PMID:
15930203
7.

Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.

Fone KC, Nutt DJ.

Curr Opin Pharmacol. 2005 Feb;5(1):87-93. Review.

PMID:
15661631
8.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

9.

An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.

Chavez B, Sopko MA Jr, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.

Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26. Review.

PMID:
19470858
10.

Stimulant drugs for severe hyperactivity in childhood.

[No authors listed]

Drug Ther Bull. 2001 Jul;39(7):52-4. Review.

PMID:
11471516
11.

[Graphomotor functions in children with attention deficit hyperactivity disorder (ADHD)].

Stasik D, Tucha O, Tucha L, Walitza S, Lange KW.

Psychiatr Pol. 2009 Mar-Apr;43(2):183-92. Review. Polish.

PMID:
19697788
12.

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f. Review.

PMID:
18480677
13.

Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis.

Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N, Taylor E, Casey BJ, Castellanos FX, Wadhwa PD.

Neuropsychol Rev. 2007 Mar;17(1):39-59. Review.

PMID:
17318414
14.

Attention-deficit/hyperactivity disorder: neurophysiology, information processing, arousal and drug development.

Rowe DL, Hermens DF.

Expert Rev Neurother. 2006 Nov;6(11):1721-34. Review.

PMID:
17144785
15.

Clinical review: evidence-based diagnosis and treatment of ADHD in children.

Nair J, Ehimare U, Beitman BD, Nair SS, Lavin A.

Mo Med. 2006 Nov-Dec;103(6):617-21. Review.

PMID:
17256270
16.

The science of stimulant abuse.

Greenhill LL.

Pediatr Ann. 2006 Aug;35(8):552-6. Review.

PMID:
16986449
17.

The neurological basis of attention deficit hyperactivity disorder.

Ballard S, Bolan M, Burton M, Snyder S, Pasterczyk-Seabolt C, Martin D.

Adolescence. 1997 Winter;32(128):855-62. Review.

PMID:
9426808
18.

Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.

Harpin VA.

Arch Dis Child Educ Pract Ed. 2008 Apr;93(2):58-65. doi: 10.1136/adc.2006.106864. Review.

PMID:
18356307
20.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk